User-Producer Interactions in Emerging Pharmaceutical and Food Innovations

Moors, Ellen H.M.; Boon, Wouter; Nahuis, Richard; Vandeberg, Rens

doi:10.1142/s1363919608001984

Cited by 14 publications

(2 citation statements)

References 48 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This approach is consonant with contemporary research that emphasises the importance of the user's voice in understanding salient factors in product development and the innovation process (e.g., Moors et al, 2008) and the increasing role of users and user groups in the development of innovations. In the current study, this was not one of the factors which we examined, but future studies might explore the extent to which user involvement shapes the attribute configurations of innovations thus rendering them more adoptable.…”

Section: Discussionmentioning

confidence: 68%

A Taxonomy of Innovation: Configurations of Attributes in Healthcare Innovations

Adams

Tranfield

Denyer

2011

Int. J. Innov. Mgt.

View full text Add to dashboard Cite

In spite of the continued importance of an innovation's attributes to research methodologies, and the increasing tendency toward multidimensional conceptualizations, the lack of a theoretically derived and empirically developed classification of innovations, conceived in terms of these perceived characteristics, continues to deter substantive research in the area. The absence of a stable descriptive framework has constrained researchers' facility to develop cross-case and cumulative research. In this paper, in which innovations are conceptualized as complex and multi-dimensional, we report on a mixed-method, exploratory study addressing the question of innovation classification. Data from a rigorous thematic investigation of the literature and four case studies, are synthesized into a descriptive framework incorporating 13 variables (innovation attributes). Following operationalization of the framework, we conduct a cluster analysis of the returns from a post-adoption survey of 310 innovations. Three distinct innovation types are identified: readily-adopted, challenging and under-cover. The attributes disruption, observability, profile and risk were found to be particularly important in distinguishing clusters that offer opportunities for new theoretical development. The UK National Health Service (NHS) forms the context for the study. Implications for theory and practice are examined.

show abstract

Section: Discussionmentioning

confidence: 68%

A Taxonomy of Innovation: Configurations of Attributes in Healthcare Innovations

Adams

Tranfield

Denyer

2011

Int. J. Innov. Mgt.

View full text Add to dashboard Cite

show abstract

“…With upstream involvement users become active agents themselves, who participate in the process of research, design and development. Upstream involvement is a learning process, because users often do not have precise knowledge, demands, needs and requirements in advance [32][33][34].…”

Section: Upstream Involvementmentioning

confidence: 99%

User producer interaction in context

Nahuis

Moors

Smits

2012

Technological Forecasting and Social Change

View full text Add to dashboard Cite

User producer interaction (UPI) increases chances for successful innovations. It is not always clear, however, what type of interaction is necessary in a particular context. This article identifies seven different types of UPI: constructing linkages, broadening, characterizing users, upstream involvement, first user enrollment, feedback, and downstream innovation. Specific contextual dimensions from which these UPI types derive relevance are discussed. The technological dimension of this context is conceptualized based on a distinction between types of technologies that differ in the degree to which they are customizable to user demands. Four case studies show that technological characteristics indeed matter for UPI, as do the heterogeneity of users and the phase of technology development.

show abstract

The Future of Psychopharmacological Enhancements: Expectations and Policies

et al. 2009

View full text Add to dashboard Cite

The hopes and fears expressed in the debate on human enhancement are not always based on a realistic assessment of the expected possibilities. Discussions about extreme scenarios may at times obscure the ethical and policy issues that are relevant today. This paper aims to contribute to an adequate and ethically sound societal response to actual current developments. After a brief outline of the ethical debate concerning neuro-enhancement, it describes the current state of the art in psychopharmacological science and current uses of psychopharmacological enhancement, as well as the prospects for the near future. It then identifies ethical issues regarding psychopharmacological enhancements that require attention from policymakers, both on the professional and on the governmental level. These concern enhancement research, the gradual expansion of medical categories, off-label prescription and responsibility of doctors, and accessibility of enhancers on the Internet. It is concluded that further discussion on the advantages and drawbacks of enhancers on a collective social level is still needed.

show abstract

User-Producer Interactions in Emerging Pharmaceutical and Food Innovations

Cited by 14 publications

References 48 publications

A Taxonomy of Innovation: Configurations of Attributes in Healthcare Innovations

A Taxonomy of Innovation: Configurations of Attributes in Healthcare Innovations

User producer interaction in context

The Future of Psychopharmacological Enhancements: Expectations and Policies

Contact Info

Product

Resources

About